Hawaii House Bill HB2221

Hawaii 2024 Regular Session

• Introduced: 1/24/24
• Refer: 1/26/24

Caption

Relating To The Hawaii Cancer Research Special Fund.

Impact

The bill modifies existing statutes, mandating significant changes to how tobacco settlement funds are allocated in order to support cancer research efforts. By redirecting a portion of these funds, the bill serves to not only bolster cancer research but also align funding with broader health objectives within the state. These legislative adaptations can substantially impact the current framework concerning health funding, financial oversight, and research priorities, fostering a more robust health care landscape in Hawaii.

Summary

House Bill 2221 (HB2221) seeks to enhance funding for cancer research in Hawaii by appropriating a portion of the tobacco settlement moneys to the Hawaii Cancer Research Special Fund. This bill aims to support the development and operation of cancer research initiatives within the state. The proposed fund will ensure that financial resources are directed towards cancer research programs, potentially leading to advances in treatment and improved health outcomes for the citizens of Hawaii. HB2221 outlines specific allocations, including appropriations to a new medical school facility and various health initiatives.

Contention

A notable aspect of HB2221 is the allocation percentage of tobacco settlement moneys. This raises questions and concerns among stakeholders regarding the impact on existing allocations to other funds, such as the tobacco prevention and control trust fund. Discussions around HB2221 may reflect a larger dialogue about health prioritization in state funding and how various health initiatives can coexist while competing for limited resources—a crucial point of contention among legislators and public health advocates.